Diversity and Function of Mutations in P450 Oxidoreductase in Patients with Antley-Bixler Syndrome and Disordered SteroidogenesisNingwu Huang, Walter L. Miller, Ethylin Wang Jabs et al.|The American Journal of Human Genetics|2005Cited by 348
Correlation of baseline ENPP1 and cGAS expression in advanced solid tumors with intratumoral immune activation and clinical outcomes after treatment with the first-in-class oral ENPP1 inhibitor RBS2418, alone or in combination with pembrolizumab.Thomas U. Marron, Jamal Misleh, Zev A. Wainberg et al.|Journal of Clinical Oncology|2024Cited by 3
Completed phase 1a dose escalation study of the first oral ENPP1 inhibitor RBS2418 immunotherapy in subjects with metastatic solid tumors.Thomas U. Marron, Jamal Misleh, Zev A. Wainberg et al.|Journal of Clinical Oncology|2025Cited by 1